Expanding access to adolescent gender-affirming care in a changing legal landscape
Even before the change in national leadership, access to adolescent gender-affirming care was becoming more difficult, with many barriers faced by these at-risk patients.
RSV prophylaxis: Palivizumab, nirsevimab, and more
Current prevention strategies include 2 injectables for infants and young children, namely palivizumab and nirsevimab.
Pediatricians and foster care: A vital role
Research shows that nearly 80% of foster children have at least 1 significant mental health need.
FDA, HHS announces plan to enhance quality, safety of domestic infant formula
The federal agencies are encouraging companies to develop new infant formulas and clarify opportunities to inform consumers about formula ingredients.
Vimkunya chikungunya vaccine launches for ages 12 years and older
Prior to approval on February 14, 2025, the only FDA approved vaccine for chikungunya protection was indicated for 18 years and up.
Higher air lead concentration linked to increased infant mortality
A study finds air lead exposure increases infant mortality, linking emissions to low birthweight, SUID, and respiratory issues, urging stricter regulations.
